Abstract:Background: Co-infection of hepatitis virus is common in human immunodeficiency virus (HIV) infected adults in China. But little is known about hepatitis virus co-infection in pediatric HIV-infected subjects. The study aimed to investigate the impact of hepatitis B virus (HBV) and/or hepatitis C virus (HCV) co-infection and highly active antiretroviral therapy (HAART) on liver function of pediatric HIV-infected subjects. Materials and Methods: A cohort study including 101 pediatric HIV-infected subjects with HBV/HCV co-infection and 44 pediatric comparators with HIV mono-infection was carried out in Henan Province of China from September 2011 to September 2012. All patients received HAART for 1-year. HBV and HCV infection was determined by antibody tests. HIV RNA load, CD4+ T-cell counts and liver function were determined before and after HAART. The Student's t-test or a one-way ANOVA was used for normally distributed values and A Mann-Whitney U-test was performed for values without normal distribution using SPSS statistical package 18.0 (SPSS Inc.). Results: After HAART for 1-year, the median levels of viral load were decreased to lower limit of detection in 90.34% pediatric HIV-infected subjects with/without HBV/HCV co-infection (P < 0.001), and CD4+ T-cell counts increased significantly (P < 0.001). Compared with the pre-HAART, mean level of alanine aminotransferase (ALT) in each group had a significant increase after HAART (P < 0.01). The mean levels of ALT and aspartate aminotransferase (AST) in nevirapine (NVP) based HAART group increased significantly after HAART (P < 0.01). Mean change values of ALT and AST were significantly higher in the NVP based regimen group than in the efavirenz (EFV) based regimen group (P < 0.01). For HIV/HBV/HCV co-infected patients, mean change values of ALT and AST in NVP-based HAART group was significantly higher than that in EFV-based HAART group (P < 0.01). Conclusion: Highly active antiretroviral therapy can damage liver function in pediatric HIV-infected subjects, especially in those with HBV/HCV co-infection. NVP was more harmful to liver function of pediatric HIV-infected subjects than EFV.

Impact of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta-Analysis

Prevalence of hepatitis B and C in HIV-infected patients: a meta-analysis.

Impact of HIV-1 Infection on the Natural Progress of an Anti-HCV Positive Population in an Impoverished Village in China from 2009 to 2017.

[Influence of HIV Infection on Hepatitis C Progress in Patients Co-Infected with HIV/HCV].

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients

The Effect of Highly Active Antiretroviral Therapy on Liver Function in Human Immunodeficiency Virus-Infected Pediatric Patients with or Without Hepatitis Virus Co-Infection

Significant Association Between HIV Infection and Increased Risk of COVID-19 Mortality: a Meta-Analysis Based on Adjusted Effect Estimates

Impact of hepatitis B virus infection on efficacy of combined antiretroviral therapy in patients with acquired immunodeficiency syndrome

Biological characteristics and survival analysis in HIV/HCV co-infected patients

Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected Patients

Hepatitis C Virus Load is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in Hemophiliacs.

Impact of Hepatitis B Virus Infection on HIV Response to Antiretroviral Therapy in a Chinese Antiretroviral Therapy Center.

Risk factors of death in HIV/HCV co-infected patients with combined antiretroviral therapy

Retrospective Analysis of Human Immunodeficiency Virus Combined with Hepatitis C Virus

[Highly Active Antiretroviral Therapy on Liver Function in HIV-positive Children with HBV/HCV Co-Infection].

Factors affecting liver fibrosis in human immunodeficiency virus–and hepatitis C virus–coinfected patients: Impact of protease inhibitor therapy

Effects of HIV Infection on Prognosis of HCV Infected Former Blood Donors

HIV Co-Infection Accelerates Decay of Humoral Responses in Spontaneous Resolvers of HCV Infection.

Comparative Analysis of Presentation and Outcome after Liver Resection of Patients with Hepatocellular Carcinoma with and Without HIV

Analysis of Liver-Related Mortality among Human Immunodeficiency Virus Infected Patients after Blood Donation Who Received Combined Antiretroviral Therapy

Prevalence and Risk Factors of End-Stage Liver Disease in a Cohort of Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients Treated with Antiretroviral Therapy